Health System Barriers to the Discussion of Breast Reconstruction Options in Australia: Improving Access Through Appropriate Referral

Kathy Flitcroft (1), Meagan Brennan (2), Andrew Spillane (3)
(1) he University of Sydney, Northern Clinical School, Sydney, Australia AND Breast & Surgical Oncology, The Poche Centre, Sydney, Australia, Australia,
(2) he University of Sydney, Northern Clinical School, Sydney, Australia AND The University of Notre Dame, Sydney,128-140 Broadway Chippendale NSW 2007, Australia AND Westmead Hospital, Hawkesbury Rd Westmead NSW 2145, Australia, Australia,
(3) he University of Sydney, Northern Clinical School, Sydney, Australia AND Breast & Surgical Oncology, The Poche Centre, Sydney, Australia, Australia

Abstract

Background: This study aimed to document referral-based barriers impeding Australian women's informed decision-making about breast reconstruction (BR) and to propose a designated BR referral pathway to help overcome these barriers.
Methods: Semi-structured, in-depth interviews were conducted with ten women previously treated for breast cancer, 9 breast and reconstructive surgeons and 6 health professionals [n=25] who had identified problems with referrals for BR.
Results: Referral-based barriers to BR discussion were identified at three different levels: from a public or private screening center to a General Practitioner (GP) or breast surgeon; from a GP to a breast surgeon; and from one breast surgeon (without BR skills) to another breast or plastic reconstructive surgeon (with BR skills). A lack of designated referral pathways has meant that clinically eligible women who are interested in considering immediate BR have been denied this opportunity.
Conclusions: Streamlining referral processes, along with patient and clinician education, would help to ensure that women are at least seen by the most appropriate clinicians to discuss BR options and to maximise their opportunity for BR should they choose that option. Designated referral pathways could also be useful in ensuring that preference-sensitive treatment decisions are facilitated in settings with varying degrees of resources and in a range of clinical conditions.

Full text article

Generated from XML file

References

Chen W, Lv X, Xu X, Gao X, Wang B. Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer. Breast Cancer. 2018;25(4):464-9.

Fanakidou I, Zyga S, Alikari V, Tsironi M, Stathoulis J, et al. Mental health, loneliness, and illness perception outcomes in quality of life among young breast cancer patients after mastectomy: the role of breast reconstruction. Quality of Life Research. 2018;27(2):539-43.

Howes BH, Watson DI, Xu C, Fosh B, Canepa M, et al. Quality of life following total mastectomy with and without reconstruction versus breast-conserving surgery for breast cancer: A case-controlled cohort study. J Plast, Reconstr, Aesthetic Surg. 2016;69(9):1184-91.

National Clinical Audit Support Programme. A national audit of provision and outcomes of mastectomy and breast reconstruction surgery for women in England. London: The Information Centre NHS; 2011.

Platt J, Zhong T. Patient-Centered Breast Reconstruction Based on Health-Related Quality-of-Life Evidence. Clinics in Plastic Surgery. 2018;45(1):137-43.

Biganzoli L, Marotti L, Hart C, Cataliotti L, Cutuli B, et al. Quality indicators in breast cancer care: An update from the EUSOMA working group. Eur J Cancer. 2017;86:59-81.

National Breast and Ovarian Cancer Centre (NBOCC) and the Royal Australasian College of Surgeons (RACS). National Breast Cancer Audit – Public Health Monitoring Report on 2007 Data. Sydney; 2009.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Breast Cancer. 2017.

National Institute for Health and Care Excellence (NICE). NICE Guidelines. Breast Cancer (Early & Locally Advanced) London: NICE; 2009.

Cancer Australia. Influencing best practice in breast cancer. Practice 11. 2016.

Flitcroft K, Brennan M, Costa D, Spillane A. Regional variation in immediate breast reconstruction rates in Australia. Br J Surg Open 2017;1:114-21.

Régis C, Le J, Chauvet MP, Le Deley MC, Le Teuff G. Variations in the breast reconstruction rate in France: A nationwide study of 19,466 patients based on the French medico-administrative database. Breast. 2018;42:74-80.

Sisco M, Du H, Warner JP, Howard MA, Winchester DP, et al. Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg. 2012;215(5):658-66.

Jeevan R, Cromwell DA, Browne JP, Caddy CM, Pereira J, et al. Findings of a national comparative audit of mastectomy and breast reconstruction surgery in England. J Plast, Reconstr, Aesthetic Surg. 2014;67(10):1333-44.

Cancer Australia. Breast Cancer in Australia [Available from: https://breast-cancer.canceraustralia. gov.au/statistics.

Flitcroft K, Brennan M, Spillane A. Making decisions about breast reconstruction: A systematic review of patient-reported factors influencing choice. Quality of Life Research. 2017:1-33.

Brennan ME, Spillane AJ. Uptake and predictors of post-mastectomy reconstruction in women with breast malignancy - Systematic review. Eur J Surg Oncol. 2013;39:527-41.

Matrai Z, Kenessey I, Savolt A, Ujhelyi M, Bartal A, et al. Evaluation of patient knowledge, desire, and psychosocial background regarding postmastectomy breast reconstruction in Hungary: a questionnaire study of 500 cases. Med Sci Monit. 2014;20:2633-42.

Somogyi R, Webb A, Baghdikian N, Stephenson J, Edward K, et al. Understanding the factors that influence breast reconstruction decision making in Australian women. Breast. 2015;24(2):124-30.

Flitcroft K, Brennan M, Spillane A. The impact on Australian women of lack of choice of breast reconstruction options: A qualitative study. Psycho-oncology. 2019;28(3):547-2.

de Ligt KM, van Bommel ACM, Schreuder K, Maduro JH, Vrancken Peeters MTFD, et al. The effect of being informed on receiving immediate breast reconstruction in breast cancer patients. Eu J Surg Oncol. 2018;44(5):717-24.

Ishak A, Yahya MM, Halim AS. Breast Reconstruction After Mastectomy: A Survey of Surgeons’ and Patients’ Perceptions. Clinical Breast Cancer. 2018;18(5):e1011-e21.

Australian Institute of Health and Welfare (AIHW). BreastScreen Australia monitoring report 2014-2015 Canberra: AIHW; 2017.

Potter S, Mills N, Cawthorn S, Wilson S, Blazeby J. Exploring inequalities in access to care and the provision of choice to women seeking breast reconstruction surgery: a qualitative study. Br J Cancer. 2013;109(5):1181-91.

Cancer Care Ontario (CCO). Breast cancer treatment pathway map. Version 2015.11 ed. Toronto, Ontario: CCO; 2015.

Somogyi RB, Ziolkowski N, Osman F, Ginty A, Brown M. Breast reconstruction: Updated overview for primary care physicians. Can Fam Physician. 2018;64(6):424-32+e255-e64.

National Cancer Expert Reference Group. Optimal Care Pathway for Women with Breast Cancer. Melbourne: Victorian Department of Health and Human Services; 2016.

Breast Cancer Network Australia (BCNA). [Available from: https://www.bcna.org.au/

Reclaim Your Curves (RYC). [Available from: https://www.reclaimyourcurves.org.au/.

Authors

Kathy Flitcroft
kathy.flitcroft@melanoma.org.au (Primary Contact)
Meagan Brennan
Andrew Spillane
Author Biographies

Kathy Flitcroft, he University of Sydney, Northern Clinical School, Sydney, Australia AND Breast & Surgical Oncology, The Poche Centre, Sydney, Australia

Dr Kathy Flitcroft is a post-doctoral Research Fellow with the Breast & Surgical Oncology team at the Poche Centre in North Sydney. She is an experienced qualitative health and health policy researcher with a PhD in public health, a master’s degree in government, a graduate certificate in health policy, an undergraduate degree in behavioural sciences and registered nurse qualifications. Kathy’s main research interest is the translation of evidence into cancer policy and practice. Kathy is passionate about facilitating informed choice for patients, particularly in relation to options for breast reconstruction, and in providing access to psychosocial support for melanoma patients.

Meagan Brennan, he University of Sydney, Northern Clinical School, Sydney, Australia AND The University of Notre Dame, Sydney,128-140 Broadway Chippendale NSW 2007, Australia AND Westmead Hospital, Hawkesbury Rd Westmead NSW 2145, Australia

Associate Professor Meagan Brennan is a Breast Physician with expertise in the diagnostic work-up of women with breast symptoms. Meagan’s research interests include survivorship care and breast imaging, as well as breast cancer in Aboriginal and Torres Strait Islander women and women from culturally diverse backgrounds. Meagan has been a leader in developing the role of the breast physician in the cancer team and has over 60 peer reviewed publications.  She is a Clinical Associate Professor at Sydney Medical School and also holds a Staff Specialist appointment at Westmead Hospital. She teaches at the University of Sydney and the University of Notre Dame.

Andrew Spillane, he University of Sydney, Northern Clinical School, Sydney, Australia AND Breast & Surgical Oncology, The Poche Centre, Sydney, Australia

Andrew Spillane is Professor of Surgical Oncology at The University of Sydney, Northern Clinical School. He specialises in the surgical and clinical management, as well as translational research, of breast cancer and melanoma. Andrew has over 150 publications and his current research interests investigate issues around quality assurance in surgery, safe introduction of new surgical techniques and promoting clinical trial involvement by surgeons. He is former President of Breast Surgeons of Australia and New Zealand and remains a clinical and research leader in this area. He lectures and teaches students at The University of Sydney Northern Clinical School.

1.
Flitcroft K, Brennan M, Spillane A. Health System Barriers to the Discussion of Breast Reconstruction Options in Australia: Improving Access Through Appropriate Referral. Arch Breast Cancer [Internet]. 2020 Nov. 16 [cited 2024 May 21];:168-77. Available from: https://www.archbreastcancer.com/index.php/abc/article/view/315

Article Details